Build a Multi-Specialty Oncology Network With In-House Ancillaries

1. 1

   Model the ancillary business case

   In-house PET/CT, pathology, and lab testing generate diagnostic revenue that otherwise leaves the practice, and they speed up the diagnostic workup that drives treatment decisions. Model utilization honestly: expensive imaging and lab equipment only pays back at sufficient volume. This is a capital-intensive bet on your own patient throughput.

2. 2

   Clear the self-referral compliance question

   Referring patients to imaging and lab services the practice owns implicates Stark Law, though the in-office ancillary services exception is often the structural basis for doing it legally. A healthcare attorney must confirm your arrangement fits an exception before you build. Compliance is the gating item, not the equipment budget.

3. 3

   Build imaging and diagnostic capacity

   PET/CT is a major capital and facility commitment, including radiopharmaceutical handling and radiation-safety compliance. Pathology and clinical labs require CLIA certification and accreditation such as CAP. Each ancillary is effectively its own regulated business inside the network.

4. 4

   Integrate the diagnostic-to-treatment pathway

   The care-continuity advantage only materializes if imaging, pathology, and treatment teams actually coordinate, with fast turnaround feeding tumor boards and treatment planning. Build shared systems and workflows across the specialties. Continuity is the clinical value that justifies the model beyond revenue capture.

5. 5

   Staff the specialist and technical teams

   Pathologists, radiologists or nuclear medicine physicians, technologists, and lab scientists in addition to the oncology team. Each discipline has its own licensing and staffing market. Recruiting and retaining these specialists is a real constraint on how fast the network can scale.

6. 6

   Diversify against drug-margin erosion

   The strategic reason to build ancillaries is that oncology drug margins are under sustained pressure, and diagnostic revenue diversifies the practice away from that single exposure. Treat ancillaries as the hedge that makes the group durable. Monitor reimbursement across all service lines because payer policy shifts constantly.

Do not take our word for the money. Put your own numbers in and see what this idea has to earn before it works. Free, instant, no account needed.